Preclinical research suggests it may support recovery by enhancing tissue repair and reducing inflammation, but results depend on consistent use rather than timing
In one study, people taking tesamorelin lost about 0.9 pounds, while those on placebo had no change in body weight
Clinical symptom resolution within days of elimination suggests hereditary fructose intolerance and can be confirmed by molecular diagnosis on DNA obtained from peripheral leukocytes (68)
DOI: Published online: November 25, 2024 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea 2 Institute of Clinical Chemistry and Laboratory Medicine, University Greifswald, Greifswald, Germany 3 Diabetes, Endocrinology, Metabolism Section, Katholisches Klinikum Bochum, St